We are monitoring the impact of COVID-19 on APAC Transplant Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date March, 2021
ID: 11381
Share on
Share on

APAC Transplant Diagnostics Market Research Report – Segmented By Technology, Product, Application, Type, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends, COVID-19 Impact and Growth Forecast (2021 to 2026)

Pulished: March, 2021
ID: 11381
Pages: 100

APAC Transplant Diagnostics Market Size (2021 to 2026)

The size of the Asia-Pacific transplant diagnostics market is forecasted to be growing at a healthy rate during the forecast period.

The growth of the transplant diagnostics market in Asia-Pacific is majorly driven by increasing organ transplants, technological advancements, and acceleration in demand for transplant procedures. The adoption of transplant diagnostics is significantly growing in the recent past. On the other hand, the high prevalence of chronic diseases and advanced technologies that have been adopted in transplant diagnostics to provide advanced diagnostic options to organ transplantation management are further contributing to the growth rate of the market. India and China are some of the APAC's emerging nations and are expected to offer potential opportunities for the transplant diagnostics market in this region to grow further. Growing R&D activities about transplant diagnostics, increasing governments' initiatives to support transplants, and improving healthcare infrastructure are acting favorably to the market growth.

However, lack of awareness among people living in rural areas of the Asia Pacific region is one of the primary factors restricting the market growth from exploring its full potential. Also, the high costs associated with the transplants, complications of insurance schemes, social and ethical issues are considered some other challenging factors for market growth. Moreover, the difficulties with the reimbursement policies are expected to impede the market growth.

This research report on the Asia-Pacific Transplant Diagnostics Market has been segmented & sub-segmented into the following categories.

By Technology:

  • Molecular Assays
    • PCR-Based Molecular Assays
      • Real-Time PCR
      • Sequence-Specific Primer-PCR
      • Sequence-Specific Oligonucleotide-PCR
      • Other PCR-Based Molecular Assays
    • Sequencing-Based Molecular Assays
      • Sanger Sequencing
      • Next-Generation Sequencing
      • Other Sequencing Molecular Assays
  • Non-Molecular Assays

By Product:

  • Consumables
  • Instrument
  • Reagent
  • Software & Services

By Application:

  • Diagnostic Applications
    • Pre-Transplantation Diagnostics
      • Infectious Disease Testing
      • Histocompatibility Testing
      • Blood Profiling
    • Post-Transplantation Diagnostics
  • Research Applications

By Transplant Type:

  • Heart Transplant
  • Kidney Transplant
  • Liver Transplant
  • Stem Cell Transplant

By End-User:

  • Labs
  • Hospitals
  • Transplant Centres
  • Research Labs & Academic Institutes

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the APAC market is projected to dominate the global market during the forecast period and is expected to showcase the highest growth rate among all the regions.

In this regional market, China had dominated the transplant diagnostics market with a dominant market share in 2019. The availability of advanced technological devices and developed healthcare infrastructure are promoting market growth.

The Japanese market is projected to record the fastest growth rate during the forecast period. According to the statistics published by biomedcentral.com, an estimated 1742 kidney transplants happened in Japan in 2017, and it further stated, the number of transplants in Japan is growing significantly year over year.

The Indian market holds a substantial share in this regional market during the forecast period. Worldwide, India gets very a smaller number of organ donations every year, and as per the reports, an estimated 500,000 people die due to the scarcity of organs.

KEY MARKET PLAYERS:

Companies such as CareDx, Pacific Biosciences of California, Illumina, Thermo Fischer Scientific, GenDx, and Immucor are playing a dominating role in the APAC Transplant Diagnostics Market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Technology:
      1. Molecular Assays
        1. PCR-Based Molecular Assays
        2. Real-Time PCR
        3. Sequence-Specific Primer-PCR
        4. Sequence-Specific Oligonucleotide-PCR
        5. Other PCR-Based Molecular Assays
      2. Sequencing-Based Molecular Assays
        1. Sanger Sequencing
        2. Next-Generation Sequencing
        3. Other Sequencing Molecular Assays
        4. Non-Molecular Assays
    2. By Product
      1. Consumables
      2. Instrument
      3. Reagent
      4. Software & Services
    3. By Application
      1. Diagnostic Applications
        1. Pre-Transplantation Diagnostics
          1. Infectious Disease Testing
          2. Histocompatibility Testing
          3. Blood Profiling
        2. Post-Transplantation Diagnostics
      2. Research Applications
    4. By Transplant Type
      1. Heart Transplant
      2. Kidney Transplant
      3. Liver Transplant
      4. Stem Cell Transplant
    5. By End-User:
      1. Labs
      2. Hospitals
      3. Transplant Centers
      4. Research Labs & Academic Institutes
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
      4. Market Attractiveness Analysis      
      5.      Market Share Analysis   
    2. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. CareDx
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Pacific Biosciences of California
    3. Illumina
    4. Thermo Fischer Scientific
    5. GenDx
    6. Immucor
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and identify the regions that are still untapped.
  • The segment-level analysis in terms of technology, application, type, and market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market, including broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players and their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field, new product launches, comparative financial studies, and recent developments in the market by major companies.
  • An executive summary abridges the entire report so that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview and investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Asia Pacific Transplant Diagnostics Market, By Technology, From 2021-2026 ( USD Billion )
  2. Asia Pacific Molecular Assays Market, By Region, From 2021-2026 ( USD Billion )
  3. Asia Pacific Non-Molecular Assays Market, By Region, From 2021-2026 ( USD Billion )
  4. Asia Pacific Transplant Diagnostics Market, By Product, From 2021-2026 ( USD Billion )
  5. Asia Pacific Consumables Market, By Region, From 2021-2026 ( USD Billion )
  6. Asia Pacific Instrument Market, By Region, From 2021-2026 ( USD Billion )
  7. Asia Pacific Reagent Market, By Region, From 2021-2026 ( USD Billion )
  8. Asia Pacific Software & Services Market, By Region, From 2021-2026 ( USD Billion )
  9. Asia Pacific Transplant Diagnostics Market, By Application, From 2021-2026 ( USD Billion )
  10. Asia Pacific Diagnostic Applications Market, By Region, From 2021-2026 ( USD Billion )
  11. Asia Pacific Research Applications Market, By Region, From 2021-2026 ( USD Billion )
  12. Asia Pacific Transplant Diagnostics Market, By Transplant Type, From 2021-2026 ( USD Billion )
  13. Asia Pacific Heart Transplant Market, By Region, From 2021-2026 ( USD Billion )
  14. Asia Pacific Kidney Transplant Market, By Region, From 2021-2026 ( USD Billion )
  15. Asia Pacific Liver Transplant Market, By Region, From 2021-2026 ( USD Billion )
  16. Asia Pacific Stem Cell Transplant Market, By Region, From 2021-2026 ( USD Billion )
  17. Asia Pacific Transplant Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  18. Asia Pacific Labs Market, By Region, From 2021-2026 ( USD Billion )
  19. Asia Pacific Hospitals Market, By Region, From 2021-2026 ( USD Billion )
  20. Asia Pacific Transplant Centres Market, By Region, From 2021-2026 ( USD Billion )
  21. Asia Pacific Research Labs & Academic Institutes Market, By Region, From 2021-2026 ( USD Billion )
  22. Japan Transplant Diagnostics Market, By Technology, From 2021-2026 ( USD Billion )
  23. Japan Transplant Diagnostics Market, By Product, From 2021-2026 ( USD Billion )
  24. Japan Transplant Diagnostics Market, By Application, From 2021-2026 ( USD Billion )
  25. Japan Transplant Diagnostics Market, By Transplant Type, From 2021-2026 ( USD Billion )
  26. Japan Transplant Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  27. China Transplant Diagnostics Market, By Technology, From 2021-2026 ( USD Billion )
  28. China Transplant Diagnostics Market, By Product, From 2021-2026 ( USD Billion )
  29. China Transplant Diagnostics Market, By Application, From 2021-2026 ( USD Billion )
  30. China Transplant Diagnostics Market, By Transplant Type, From 2021-2026 ( USD Billion )
  31. China Transplant Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  32. India Transplant Diagnostics Market, By Technology, From 2021-2026 ( USD Billion )
  33. India Transplant Diagnostics Market, By Product, From 2021-2026 ( USD Billion )
  34. India Transplant Diagnostics Market, By Application, From 2021-2026 ( USD Billion )
  35. India Transplant Diagnostics Market, By Transplant Type, From 2021-2026 ( USD Billion )
  36. India Transplant Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  37. Australia Transplant Diagnostics Market, By Technology, From 2021-2026 ( USD Billion )
  38. Australia Transplant Diagnostics Market, By Product, From 2021-2026 ( USD Billion )
  39. Australia Transplant Diagnostics Market, By Application, From 2021-2026 ( USD Billion )
  40. Australia Transplant Diagnostics Market, By Transplant Type, From 2021-2026 ( USD Billion )
  41. Australia Transplant Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  42. South Korea Transplant Diagnostics Market, By Technology, From 2021-2026 ( USD Billion )
  43. South Korea Transplant Diagnostics Market, By Product, From 2021-2026 ( USD Billion )
  44. South Korea Transplant Diagnostics Market, By Application, From 2021-2026 ( USD Billion )
  45. South Korea Transplant Diagnostics Market, By Transplant Type, From 2021-2026 ( USD Billion )
  46. South Korea Transplant Diagnostics Market, By End-User, From 2021-2026 ( USD Billion )
  47. Asia Pacific Transplant Diagnostics Market, By Sequencing-Based Molecular Assays, From 2021 to 2026 (USD Million)
  48. Asia Pacific Sanger Sequencing Market, By Region, From 2021 to 2026 (USD Million)
  49. Asia Pacific Next-Generation Sequencing Market, By Region, From 2021 to 2026 (USD Million)
  50. Asia Pacific Other Sequencing Molecular Assays Market, By Region, From 2021 to 2026 (USD Million)
  51. Japan Transplant Diagnostics Market, By Sequencing-Based Molecular Assays, From 2021 to 2026 (USD Million)
  52. China Transplant Diagnostics Market, By Sequencing-Based Molecular Assays, From 2021 to 2026 (USD Million)
  53. India Transplant Diagnostics Market, By Sequencing-Based Molecular Assays, From 2021 to 2026 (USD Million)
  54. Australia Transplant Diagnostics Market, By Sequencing-Based Molecular Assays, From 2021 to 2026 (USD Million)
  55. Asia Pacific Transplant Diagnostics Market, By Molecular Assays, From 2021 to 2026 (USD Million)
  56. Asia Pacific PCR-Based Molecular Assays Market, By Region, From 2021 to 2026 (USD Million)
  57. Asia Pacific Sequencing-Based Molecular Assays Market, By Region, From 2021 to 2026 (USD Million)
  58. Japan Transplant Diagnostics Market, By Molecular Assays, From 2021 to 2026 (USD Million)
  59. China Transplant Diagnostics Market, By Molecular Assays, From 2021 to 2026 (USD Million)
  60. India Transplant Diagnostics Market, By Molecular Assays, From 2021 to 2026 (USD Million)
  61. Australia Transplant Diagnostics Market, By Molecular Assays, From 2021 to 2026 (USD Million)
  62. Asia Pacific Transplant Diagnostics Market, By PCR-Based Molecular Assays, From 2021 to 2026 (USD Million)
  63. Asia Pacific Real-Time PCR Market, By Region, From 2021 to 2026 (USD Million)
  64. Asia Pacific Sequence-Specific Primer-PCR Market, By Region, From 2021 to 2026 (USD Million)
  65. Asia Pacific Sequence-Specific Oligonucleotide-PCR Market, By Region, From 2021 to 2026 (USD Million)
  66. Asia Pacific Other PCR-Based Molecular Assays Market, By Region, From 2021 to 2026 (USD Million)
  67. Japan Transplant Diagnostics Market, By PCR-Based Molecular Assays, From 2021 to 2026 (USD Million)
  68. China Transplant Diagnostics Market, By PCR-Based Molecular Assays, From 2021 to 2026 (USD Million)
  69. India Transplant Diagnostics Market, By PCR-Based Molecular Assays, From 2021 to 2026 (USD Million)
  70. Australia Transplant Diagnostics Market, By PCR-Based Molecular Assays, From 2021 to 2026 (USD Million)
  71. Asia Pacific Transplant Diagnostics Market, By Diagnostic Applications, From 2021 to 2026 (USD Million)
  72. Asia Pacific Pre-Transplantation Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  73. Asia Pacific Post-Transplantation Diagnostics Market, By Region, From 2021 to 2026 (USD Million)
  74. Japan Transplant Diagnostics Market, By Diagnostic Applications, From 2021 to 2026 (USD Million)
  75. China Transplant Diagnostics Market, By Diagnostic Applications, From 2021 to 2026 (USD Million)
  76. India Transplant Diagnostics Market, By Diagnostic Applications, From 2021 to 2026 (USD Million)
  77. Australia Transplant Diagnostics Market, By Diagnostic Applications, From 2021 to 2026 (USD Million)
  78. Asia Pacific Transplant Diagnostics Market, By Pre-Transplantation Diagnostics, From 2021 to 2026 (USD Million)
  79. Asia Pacific Infectious Disease Testing Market, By Region, From 2021 to 2026 (USD Million)
  80. Asia Pacific Histocompatibility Testing Market, By Region, From 2021 to 2026 (USD Million)
  81. Asia Pacific Blood Profiling Market, By Region, From 2021 to 2026 (USD Million)
  82. Japan Transplant Diagnostics Market, By Pre-Transplantation Diagnostics, From 2021 to 2026 (USD Million)
  83. China Transplant Diagnostics Market, By Pre-Transplantation Diagnostics, From 2021 to 2026 (USD Million)
  84. India Transplant Diagnostics Market, By Pre-Transplantation Diagnostics, From 2021 to 2026 (USD Million)
  85. Australia Transplant Diagnostics Market, By Pre-Transplantation Diagnostics, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample